FIELD: biochemistry, medicine.
SUBSTANCE: invention relates to the development of methods used in treatment and prophylaxis of morbid states caused by contraction of smooth muscle cells and based on using compositions comprising, for example, the following substances: ascorbic acid, 680 mg; ascorbyl palmitate, 620 mg; mixture of beta-, gamma- and delta-tocopherol, 22 mg; beta-carotene, 1665 mg; biotin, 65 mcg; calcium ascorbate, 1050 mg; calcium citrate, 200 mg; calcium glycynate, 35 mg; mixture of carotinoids (alpha-carotene, lutein, zeatin, cryptoxanthin), 50 mcg; cholecalciferol, 130 IU; chrome glycynate, 10 mcg; citrus bioflavonoids, 650 mg; coenzyme Q, 7 mg; copper glycynate, 330 mcg; cyanocobalamine, 20 mcg; d-alpha-tocopherol, 230 IU; calcium d-pantothenate , 40 mg; dicalcium phosphate, 15 mg; folic acid, 90 mcg; inositol, 35 mg; L-arginine, 790 mg; L-cysteine, 35 mg; L-lysine, 110 mg; L-proline, 110 mg; L-selenomethionine, 20 mcg; magnesium ascorbate. 1050 mg; magnesium citrate, 40 mg; magnesium glycynate, 40 mg; manganese chelate, 1300 mcg; molybdenum glycynate, 4 mcg; nicotinic acid, 10 mg; nicotinamide, 35 mg; potassium chelate, 20 mg; picnogenol, 7 mg; pyridoxine, 10 mg; riboflavin, 7 mg; thiamine, 7 mg, and zinc glycynate, 7 mg. Invention provides enhancing effectiveness in relief of morbid states associated with contraction of smooth muscles.
EFFECT: enhanced effectiveness and valuable medicinal properties of compositions.
4 cl, 2 tbl, 1 ex
